Master in Biomedical Omics

For Master in Biomedical Omics, tuition comes to 4,489 USD per year.

Biomedical Omics is a master's program at Università degli Studi di Milano, taught in English in Milano, Italy, over two years, aimed at students with a background in biology, biotechnology, or a related biomedical field. The discipline studies large-scale biological data generated by omics technologies, including genomics, transcriptomics, proteomics, and metabolomics, and applies that data to understanding health and disease. Students typically study molecular biology and biochemistry alongside the laboratory and computational techniques used to generate and analyze omics data, such as sequencing, mass spectrometry, and bioinformatics tools for processing large datasets. Coursework often covers how integrating multiple omics layers can reveal disease mechanisms, biomarkers, and potential drug targets, reflecting a broader shift in biomedical research toward combining molecular data types rather than studying genes or proteins in isolation. Students also typically gain experience with statistical and computational methods needed to handle the scale and complexity of omics datasets, along with an understanding of how these approaches are applied in clinical and pharmaceutical research settings. Graduates pursue careers in biomedical and pharmaceutical research, clinical diagnostics, biotechnology companies developing precision medicine tools, and academic or hospital-based research groups. Others continue into doctoral study focused on specific diseases or omics methodologies. The field sits at the intersection of molecular biology, data science, and medicine, requiring comfort with laboratory techniques as well as computational data analysis. Milano's concentration of biomedical research institutions and companies provides relevant context for this English-medium program, which trains international students in an area increasingly central to modern biomedical research and personalized medicine.